These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8330466)

  • 21. Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs.
    Grauer GF; Greco DS; Behrend EN; Fettman MJ; Mani I; Getzy DM; Reinhart GA
    Am J Vet Res; 1996 Jun; 57(6):948-56. PubMed ID: 8725828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects.
    Khosravan R; Grabowski BA; Wu JT; Joseph-Ridge N; Vernillet L
    Clin Pharmacokinet; 2006; 45(8):821-41. PubMed ID: 16884320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents].
    Delbarre F; Saporta L; de Géry A; Jabre E
    Rev Rhum Mal Osteoartic; 1970; 37(6):443-50. PubMed ID: 5453852
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects.
    Guth BD; Narjes H; Schubert HD; Tanswell P; Riedel A; Nehmiz G
    Br J Clin Pharmacol; 2004 Jul; 58(1):40-51. PubMed ID: 15206991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diuretic and uricosuric effects of traxanox sodium in healthy subjects. Single dose study.
    Ebihara A; Tsuru M; Ohashi K; Fujimura A; Kondo K
    Arzneimittelforschung; 1987 Dec; 37(12):1388-91. PubMed ID: 3329516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypouricemic and uricosuric actions of AA-193 in a hyperuricemic rat model.
    Dan T; Yoneya T; Onoma M; Onuma E; Ozawa K
    Metabolism; 1994 Jan; 43(1):123-8. PubMed ID: 8289669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective and nonselective inhibition of thromboxane formation.
    FitzGerald GA; Oates JA
    Clin Pharmacol Ther; 1984 May; 35(5):633-40. PubMed ID: 6370554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic approach to the maintenance of urate homeostasis.
    Kelley WN
    Nephron; 1975; 14(1):99-115. PubMed ID: 1091870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uricosuric effect of irtemazole in healthy subjects.
    Gresser U; Zöllner N
    Klin Wochenschr; 1989 Oct; 67(19):971-5. PubMed ID: 2615290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental study on certain methods of decreasing the urinary excretion of uric acid.
    Sorrentino F
    Urol Int; 1970; 25(5):444-56. PubMed ID: 5525133
    [No Abstract]   [Full Text] [Related]  

  • 32. Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone.
    Ahn SO; Ohtomo S; Kiyokawa J; Nakagawa T; Yamane M; Lee KJ; Kim KH; Kim BH; Tanaka J; Kawabe Y; Horiba N
    J Pharmacol Exp Ther; 2016 Apr; 357(1):157-66. PubMed ID: 26907620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects.
    Yoon S; Shin D; Lee H; Jang IJ; Yu KS
    Drug Des Devel Ther; 2015; 9():5033-49. PubMed ID: 26357467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Pimenta pseudocaryophyllus extracts on gout: Anti-inflammatory activity and anti-hyperuricemic effect through xantine oxidase and uricosuric action.
    Ferrari FC; Lemos Lima Rde C; Schimith Ferraz Filha Z; Barros CH; de Paula Michel Araújo MC; Antunes Saúde-Guimarães D
    J Ethnopharmacol; 2016 Mar; 180():37-42. PubMed ID: 26778678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of bovine milk ingestion on urinary excretion of oxypurinol and uric acid.
    Kurajoh M; Ka T; Okuda C; Yamamoto A; Tsutsumi Z; Koyama H; Moriwaki Y; Yamamoto T
    Int J Clin Pharmacol Ther; 2011 Jun; 49(6):366-70. PubMed ID: 21612743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of low-dose aspirin and specific thromboxane synthetase inhibition on whole blood platelet aggregation and adenosine triphosphate secretion in healthy dogs.
    Grauer GF; Rose BJ; Toolan L; Thrall MA; Colgan SP
    Am J Vet Res; 1992 Sep; 53(9):1631-5. PubMed ID: 1416368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of antihyperuricemic effect of Phyllanthus niruri and its lignan constituents.
    Murugaiyah V; Chan KL
    J Ethnopharmacol; 2009 Jul; 124(2):233-9. PubMed ID: 19397979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The uricosuric effects of dihydropyridine calcium channel blockers in vivo using urate under-excretion animal models.
    Hori T; Ouchi M; Otani N; Nohara M; Morita A; Otsuka Y; Jutabha P; Shibasaki I; Matsushita Y; Fujita T; Fukuda H; Anzai N
    J Pharmacol Sci; 2018 Apr; 136(4):196-202. PubMed ID: 29656005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effect of CGS 13080, a thromboxane synthase inhibitor, in suppressing serum and urine immunoreactive thromboxane B2 in kidney transplant patients.
    Foegh ML; Lim K; Douglas F; Turk J; Helfrich GB; Taher SA; Alijani MR
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):424-7. PubMed ID: 3279631
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetic and pharmacodynamic properties of a novel xanthine oxidase inhibitor, BOF-4272, in healthy volunteers.
    Uematsu T; Nakashima M
    J Pharmacol Exp Ther; 1994 Aug; 270(2):453-9. PubMed ID: 8071837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.